Skip to content

Warby Parker WRBY Additional Paid-In Capital

Additional Paid-In Capital at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$782.84M+7.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.98B+2.1%
Glaukos logo
GlaukosGKOS
$1.62B+6.3%

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's additional paid-in capital?
Warby Parker (WRBY) reported additional paid-in capital of $1.06B in Q1 2026.
How has Warby Parker's additional paid-in capital changed year-over-year?
Warby Parker's additional paid-in capital increased by 1.9% year-over-year, from $1.04B to $1.06B.
What is the long-term trend for Warby Parker's additional paid-in capital?
Over 5 years (2020 to 2025), Warby Parker's additional paid-in capital has grown at a 52.7% compound annual growth rate (CAGR), from $127.18M to $1.05B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.